Medico Remedies' Stock Hits 52-Week Low, Underperforms Sector by -1.57%
Medico Remedies, a microcap pharmaceutical company, has hit a 52-week low in its stock price, reaching Rs. 44.15 on May 7th, 2024. The stock has been consistently falling and is currently trading below its moving averages. Compared to the Sensex, the company's stock has had a negative 1-year performance of -48.67%.
Medico Remedies, a microcap pharmaceutical company, has recently hit a 52-week low in its stock price. On May 7th, 2024, the company's stock price reached a low of Rs. 44.15, according to data from MarketsMOJO. The stock has been on a downward trend for the past two days and has underperformed the sector by -1.57%.
The company's stock has also been consistently falling, with a -4.02% return in the period. On the same day, the stock touched an intraday low of Rs. 44.15, a decrease of -2.47%. Medico Remedies is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In comparison to the Sensex performance of 20.45%, Medico Remedies has had a negative 1-year performance of -48.67%. This indicates that the company's stock has not been performing well in the market.
Medico Remedies is a microcap company in the pharmaceutical industry. While the company's stock has been on a downward trend, it is important to note that this article is not making any recommendations or predictions about the future potential of the company. It is simply reporting on the current stock performance based on factual data from MarketsMOJO. Investors should conduct their own research and analysis before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
